Raymond James Financial’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$240K Sell
13,722
-62,997
-82% -$832K ﹤0.01% 4951
2026
Q1
$1.26M Buy
76,719
+52,163
+212% +$1.28M ﹤0.01% 3698
2025
Q4
$701K Buy
24,556
+8,443
+52% +$229K ﹤0.01% 4016
2025
Q3
$475K Sell
16,113
-2,424
-13% -$66.3K ﹤0.01% 4148
2025
Q2
$534K Sell
18,537
-21,050
-53% -$622K ﹤0.01% 3971
2025
Q1
$1.38M Sell
39,587
-9,091
-19% -$371K ﹤0.01% 3255
2024
Q4
$2.17M Buy
+48,678
New +$1.99M ﹤0.01% 2908

Other funds holding QDEL

Raymond James Financial's QDEL Position: Q2 2026 in Review

Raymond James Financial reduced its QuidelOrtho (QDEL) stake by 82% in Q2 2026, selling an estimated $832K and leaving 13,722 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #4951.

Raymond James Financial first reported a position in QDEL in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.17M in Q4 2024. 245 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

  • Raymond James Financial held 13,722 shares of QuidelOrtho worth $240K as of Q2 2026.
  • Raymond James Financial sold 62,997 QuidelOrtho shares in Q2 2026, an estimated $832K.
  • QuidelOrtho made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4951 holding.
  • Raymond James Financial first reported a position in QuidelOrtho in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's QuidelOrtho position peaked at $2.17M in Q4 2024.
  • 245 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.